Filings
Finds words inside filing documents. Searching Foghorn Therapeutics Inc.'s filings · 63 documents indexed.
7 documents · 12 matches
-
FHTX Foghorn Therapeutics Inc. 10-K 2026-03-11
Item 1. Business
tariff on branded or patented drugs may increase the cost of drug products that are imported from abroad or manufactured3 matches in this document -
FHTX Foghorn Therapeutics Inc. 10-Q 2026-11-09
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
• experience significant operating cost increases as a result of increased inflation or increased tariffs;1 match in this document -
FHTX Foghorn Therapeutics Inc. 10-Q 2026-08-06
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
•experience significant operating cost increases as a result of increased inflation or increased tariffs;1 match in this document -
FHTX Foghorn Therapeutics Inc. 10-Q 2026-05-07
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
•experience significant operating cost increases as a result of increased inflation or increased tariffs;1 match in this document -
FHTX Foghorn Therapeutics Inc. 10-Q 2025-11-05
Item 6.
financial and economic conditions, including recessionary conditions, interest rates, monetary fluctuations, supply chain constraints, tariff uncertainty, and stock market volatility;2 matches in this document -
FHTX Foghorn Therapeutics Inc. 10-Q 2025-08-05
Item 6.
financial and economic conditions, including recessionary conditions, interest rates, monetary fluctuations, supply chain constraints, tariff uncertainty, and stock market volatility;2 matches in this document -
FHTX Foghorn Therapeutics Inc. 10-Q 2025-05-14
Item 6.
financial and economic conditions, including recessionary conditions, interest rates, monetary fluctuations, supply chain constraints, tariff uncertainty, and stock market volatility;2 matches in this document
Page 1 of 1 · 7 documents